| HOME >> BIOLOGY >> TECHNOLOGY |
About Accuray
Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 40,000 patients worldwide and currently more than 125 systems have been installed in leading hospitals in the Americas, Europe and Asia. For more information, please visit http://www.accuray.com.
Safe Harbor Statement
The foregoing may contain certain forward-looking statements that
involve risks and uncertainties, including uncertainties associated with
the medical device industry. Except for the historical information
contained herein, the matters set forth in this press release, clinical
studies, regulatory review and approval, and market acceptance and
commercialization of products and services are forward-looking statements
within the meaning of the "safe harbor" provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking statements speak
only as of the date the statements are made and are based on information
available at the time those statements are made and/or management's good
faith belief as of that time wit
'/>"/>
| SOURCE Accuray Incorporated Copyright©2008 PR Newswire. All rights reserved |